Logo image of OPRX

OPTIMIZERX CORP (OPRX) Stock Overview

USA - NASDAQ:OPRX - US68401U2042 - Common Stock

21.68 USD
+2.09 (+10.67%)
Last: 10/24/2025, 8:00:02 PM
21.82 USD
+0.14 (+0.65%)
After Hours: 10/24/2025, 8:00:02 PM

OPRX Key Statistics, Chart & Performance

Key Statistics
Market Cap402.60M
Revenue(TTM)104.75M
Net Income(TTM)-9869000
Shares18.57M
Float15.53M
52 Week High21.99
52 Week Low3.78
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.74
PE29.3
Fwd PE27.76
Earnings (Next)11-06 2025-11-06
IPO2005-05-18
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology


OPRX short term performance overview.The bars show the price performance of OPRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150

OPRX long term performance overview.The bars show the price performance of OPRX in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200 250

The current stock price of OPRX is 21.68 USD. In the past month the price increased by 15.44%. In the past year, price increased by 297.07%.

OPTIMIZERX CORP / OPRX Daily stock chart

OPRX Latest News, Press Relases and Analysis

OPRX Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 39.33 48.03B
DOCS DOXIMITY INC-CLASS A 44.86 12.52B
WAY WAYSTAR HOLDING CORP 35.11 7.44B
HTFL HEARTFLOW INC N/A 3.16B
CERT CERTARA INC 25.84 2.03B
TDOC TELADOC HEALTH INC N/A 1.67B
SDGR SCHRODINGER INC N/A 1.66B
PHR PHREESIA INC N/A 1.41B
GDRX GOODRX HOLDINGS INC-CLASS A 11.29 1.37B
CTEV CLARITEV CORP N/A 1.15B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.07B
EVH EVOLENT HEALTH INC - A N/A 917.75M

About OPRX

Company Profile

OPRX logo image OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

Company Info

OPTIMIZERX CORP

260 Charles Street, Suite 302

Waltham MASSACHUSETTS 48307 US

CEO: William Febbo

Employees: 129

OPRX Company Website

OPRX Investor Relations

Phone: 12486516558

OPTIMIZERX CORP / OPRX FAQ

What does OPTIMIZERX CORP do?

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.


What is the current price of OPRX stock?

The current stock price of OPRX is 21.68 USD. The price increased by 10.67% in the last trading session.


What is the dividend status of OPTIMIZERX CORP?

OPRX does not pay a dividend.


What is the ChartMill technical and fundamental rating of OPRX stock?

OPRX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the Price/Earnings (PE) ratio of OPTIMIZERX CORP (OPRX)?

The PE ratio for OPTIMIZERX CORP (OPRX) is 29.3. This is based on the reported non-GAAP earnings per share of 0.74 and the current share price of 21.68 USD.


Would investing in OPTIMIZERX CORP be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OPRX.


OPRX Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to OPRX. When comparing the yearly performance of all stocks, OPRX is one of the better performing stocks in the market, outperforming 98.18% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OPRX Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to OPRX. OPRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OPRX Financial Highlights

Over the last trailing twelve months OPRX reported a non-GAAP Earnings per Share(EPS) of 0.74. The EPS increased by 184.62% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -5.83%
ROE -8.27%
Debt/Equity 0.21
Chartmill High Growth Momentum
EPS Q2Q%1100%
Sales Q2Q%55.19%
EPS 1Y (TTM)184.62%
Revenue 1Y (TTM)25.9%

OPRX Forecast & Estimates

13 analysts have analysed OPRX and the average price target is 19.38 USD. This implies a price decrease of -10.61% is expected in the next year compared to the current price of 21.68.

For the next year, analysts expect an EPS growth of 105.03% and a revenue growth 18.13% for OPRX


Analysts
Analysts83.08
Price Target19.38 (-10.61%)
EPS Next Y105.03%
Revenue Next Year18.13%

OPRX Ownership

Ownership
Inst Owners71.3%
Ins Owners12.48%
Short Float %11.05%
Short Ratio5.2